查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1610302

精準心臟病學市場：按產品、樣品、技術、適應症、最終用戶分類 - 2025-2030 年全球預測

Precision Cardiology Market by Offering (Product, Service), Sample (Blood, Saliva), Technology, Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年精準心臟病學市場價值為138.4億美元，預計到2024年將達到156.7億美元，複合年成長率為12.04%，預計到2030年將達到306.8億美元。

精準心臟病學專注於透過分析患者的遺傳、表現型和生活方式因素並提供有針對性的治療來對心血管疾病 (CVD) 進行客製化管理。對精準心臟病學的需求源於心血管疾病（全球主要死亡原因）日益增加的全球負擔，需要更個人化和有效的治療策略。應用範圍涵蓋風險評估、診斷、治療監測和藥物個人化，為臨床環境、研究機構、醫療機構和生物製藥公司提供了巨大的最終使用潛力。市場成長的主要驅動力是基因組學和生物技術的進步、個人化醫療的日益採用以及臨床醫生和患者對精準醫療益處的認知不斷提高。關鍵的成長要素包括政府在基因組學方面的舉措、對醫療保健基礎設施的投資以及臨床試驗的合作研究。目前的機會包括監管適應性、與數位健康平台的整合以及向新興市場的擴張。然而，基因檢測成本的上升、複雜的監管環境、資料隱私問題以及對專業技能的需求正在限制市場的成長。用於資料分析的人工智慧創新、開發具有成本效益的基因組解決方案以及整合多組體學資料以提高準確性，都是業務擴展的有希望的途徑。此外，旨在提高相關人員意識和培養信任的綜合教育措施可以顯著加速市場採用。彌合生物技術開發和臨床應用之間差距的多學科合作也將推動業務成長。精準心臟病學市場本質上是動態的，並由快速的技術進步和不斷發展的患者照護模式所定義。為了取得成功，公司必須投資於技術開發並建立專注於綜合護理模式的策略夥伴關係關係。透過這樣做，市場參與者不僅可以利用精準心臟病學的變革潛力，還可以推動創新，改善患者的治療效果並促進醫療保健的永續性。

主要市場統計
基準年[2023] 138.4億美元
預計年份 [2024] 156.7億美元
預測年份 [2030] 306.8億美元
複合年成長率（%） 12.04%

市場動態：揭示快速發展的精準心臟病學市場的關鍵市場洞察

供需的動態交互作用正在改變精準心臟病學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 心血管疾病盛行率增加
    • 世界各地越來越重視早期疾病篩檢
  • 市場限制因素
    • 精準心臟病學相關的高成本
  • 市場機會
    • 精密心臟病學測試的技術進步
    • 政府及企業加大研發投入
  • 市場挑戰
    • 監管機構嚴格的標準和規定

波特五力：駕馭精準心臟病學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解精準心臟病學市場的外部影響

外部宏觀環境因素在塑造精準心臟病學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解精準心臟病學市場的競爭格局

對精密心臟病學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣精密心臟病學市場供應商的績效評估

FPNV定位矩陣是評估精準心臟科市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製精準心臟病學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，精準心臟病學市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病盛行率增加
      • 早期疾病篩檢的重要性在全球範圍內日益增加。
    • 抑制因素
      • 精準心臟病學相關的高成本
    • 機會
      • 精密心臟病學測試的技術進步
      • 政府及企業加大研發投入
    • 任務
      • 監管機構制定的嚴格標準和規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 精準心臟病學市場：透過提供

  • 產品
  • 服務

第 7 章 精準心臟病學市場樣本

  • 血
  • 唾液

第8章精準心臟病學市場：依技術分類

  • 微陣列
  • 次世代定序
  • 聚合酵素鏈鎖反應

第9章精準心臟病學市場（按適應症）

  • 主動脈病變和血管疾病
  • 心律不整
  • 心肌病
  • 先天性心臟疾病和症候群
  • 遺傳性高膽固醇症

第 10 章 精準心臟病學市場：依最終使用者分類

  • 學術研究所
  • 醫院和診斷實驗室

第11章美洲精準心臟病學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太精準心臟病學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的精準心臟病學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ARUP Laboratories
  • Centogene BV
  • DNA Genotek Inc. by OraSure Technologies, Inc.
  • Eurofins Scientific
  • Exact Sciences Corporation
  • Fulgent Genetics, Inc.
  • GE HealthCare Technologies Inc.
  • Genincode PLC
  • IDOVEN 1903, SL
  • Illumina, Inc.
  • Invitae Corporation
  • OPKO Health, Inc.
  • PerkinElmer Genomics
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5C6F41F5B032

The Precision Cardiology Market was valued at USD 13.84 billion in 2023, expected to reach USD 15.67 billion in 2024, and is projected to grow at a CAGR of 12.04%, to USD 30.68 billion by 2030.

Precision cardiology focuses on the tailored management of cardiovascular diseases (CVDs) by profiling patients' genetic, phenotypic, and lifestyle factors for targeted treatments. The necessity of precision cardiology arises from the rising global burden of CVDs, the leading cause of mortality worldwide, necessitating more personalized and effective treatment strategies. Applications span risk assessment, diagnostics, therapeutic monitoring, and medication personalization, providing significant end-use potential in clinical settings, research institutions, healthcare organizations, and biopharmaceutical companies. Market growth is predominantly driven by advancements in genomics and biotechnology, increasing adoption of personalized medicine, and heightened awareness of precision health benefits among clinicians and patients. Key growth enablers include government initiatives in genomics, investments in healthcare infrastructure, and collaborations for clinical trials. Current opportunities exist in regulatory adaptability, integration with digital health platforms, and expansion into emerging economies. However, market growth is constrained by high costs of genetic testing, complex regulatory landscapes, data privacy concerns, and the need for specialized skills. Innovation in artificial intelligence for data analysis, development of cost-effective genomic solutions, and integration of multi-omics data to enhance precision are promising avenues for business expansion. Moreover, comprehensive educational initiatives to increase stakeholder awareness and foster trust can substantially catalyze market adoption. Business growth can also be supported by interdisciplinary collaborations to bridge gaps between biotechnology developments and clinical applications. The precision cardiology market is inherently dynamic, defined by rapid technological advancements and evolving patient care paradigms. To succeed, companies should invest in technology development and form strategic partnerships focused on integrated care models, while also navigating the regulatory and ethical challenges inherent to the sector. By doing so, market players can not only capitalize on precision cardiology's transformative potential but also drive innovation that enhances patient outcomes and facilitates healthcare sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 13.84 billion
Estimated Year [2024] USD 15.67 billion
Forecast Year [2030] USD 30.68 billion
CAGR (%) 12.04%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Cardiology Market

The Precision Cardiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases
    • Growing emphasis on early disease screening globally
  • Market Restraints
    • High cost associated with precision cardiology
  • Market Opportunities
    • Technological advancements in precision cardiology tests
    • Rise in investment in research and development by governments and businesses
  • Market Challenges
    • Stringent standards and regulations laid by regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Precision Cardiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Cardiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Cardiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Cardiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Cardiology Market

A detailed market share analysis in the Precision Cardiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Cardiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Cardiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Cardiology Market

A strategic analysis of the Precision Cardiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Cardiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ARUP Laboratories, Centogene B.V., DNA Genotek Inc. by OraSure Technologies, Inc., Eurofins Scientific, Exact Sciences Corporation, Fulgent Genetics, Inc., GE HealthCare Technologies Inc., Genincode PLC, IDOVEN 1903, S.L., Illumina, Inc., Invitae Corporation, OPKO Health, Inc., PerkinElmer Genomics, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Cardiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Product and Service.
  • Based on Sample, market is studied across Blood and Saliva.
  • Based on Technology, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Indication, market is studied across Aortopathy and Vascular Diseases, Arrhythmia, Cardiomyopathy, Congenital Heart Defects & Syndromes, and Familial Hypercholesterolemia.
  • Based on End-User, market is studied across Academic & Research Institutes and Hospitals & Diagnostic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases
      • 5.1.1.2. Growing emphasis on early disease screening globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with precision cardiology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in precision cardiology tests
      • 5.1.3.2. Rise in investment in research and development by governments and businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent standards and regulations laid by regulatory bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Cardiology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Service

7. Precision Cardiology Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Saliva

8. Precision Cardiology Market, by Technology

  • 8.1. Introduction
  • 8.2. Microarray
  • 8.3. Next-Generation Sequencing
  • 8.4. Polymerase Chain Reaction

9. Precision Cardiology Market, by Indication

  • 9.1. Introduction
  • 9.2. Aortopathy and Vascular Diseases
  • 9.3. Arrhythmia
  • 9.4. Cardiomyopathy
  • 9.5. Congenital Heart Defects & Syndromes
  • 9.6. Familial Hypercholesterolemia

10. Precision Cardiology Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals & Diagnostic Laboratories

11. Americas Precision Cardiology Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Precision Cardiology Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Precision Cardiology Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ARUP Laboratories
  • 3. Centogene B.V.
  • 4. DNA Genotek Inc. by OraSure Technologies, Inc.
  • 5. Eurofins Scientific
  • 6. Exact Sciences Corporation
  • 7. Fulgent Genetics, Inc.
  • 8. GE HealthCare Technologies Inc.
  • 9. Genincode PLC
  • 10. IDOVEN 1903, S.L.
  • 11. Illumina, Inc.
  • 12. Invitae Corporation
  • 13. OPKO Health, Inc.
  • 14. PerkinElmer Genomics
  • 15. Quest Diagnostics Incorporated
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION CARDIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. PRECISION CARDIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECISION CARDIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION CARDIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY AORTOPATHY AND VASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CARDIOMYOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CONGENITAL HEART DEFECTS & SYNDROMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023